This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "aortopathy_tgfbeta_dysregulation#TGF-beta Signaling Dysregulation"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should substitute the disorder-specific primary lesion while preserving the conserved cascade. Key disorder-specific substitutions: Marfan and Shprintzen-Goldberg use FBN1 microfibril deficiency (with SKI in Shprintzen-Goldberg); Loeys-Dietz uses TGF-beta pathway gene mutations (TGFBR1/2, SMAD3, TGFB2/3); vascular Ehlers-Danlos uses COL3A1; arterial tortuosity syndrome uses SLC2A10 (GLUT10); and nonsyndromic familial TAAD uses smooth muscle contractile-apparatus genes (ACTA2, MYH11, MYLK, PRKG1). The shared hub and key conformance target is "TGF-beta Signaling Dysregulation". Evidence here is drawn from cross-TAAD reviews documenting the conserved cascade rather than any single disease; evidence_source is OTHER because these are reviews synthesizing multiple study types.
Aortic Wall ECM or Contractile Apparatus Defect
trigger
A monogenic loss-of-function or dominant-negative defect compromises a structural or regulatory component of the aortic wall: the fibrillin-1 microfibrils and elastic fibers of the extracellular matrix (FBN1, COL3A1, and other matrix genes), or the contractile apparatus of vascular smooth muscle cells (ACTA2, MYH11, MYLK, PRKG1). The identity of the affected gene varies by disorder, but loss of normal aortic wall architecture is the conserved trigger.
Downstream
-
TGF-beta Signaling Dysregulation
Loss of microfibrils liberates sequestered TGF-beta and pathway-gene mutations perturb signaling directly, converging on dysregulated TGF-beta activity.
TGF-beta Signaling Dysregulation
central effector
The diverse primary lesions converge on dysregulated, paradoxically increased TGF-beta signaling in the aortic wall. TGF-beta signaling is central to vascular smooth muscle cell differentiation, matrix production, and vascular homeostasis, so its dysregulation is the shared hub event of the heritable aortopathies and the key conformance target for disorder entries. Notably, even loss-of-function mutations in TGF-beta receptors produce increased aortic TGF-beta activity (the "TGF-beta paradox").
Downstream
-
Aortic Medial Degeneration and Wall Weakening
Sustained TGF-beta dysregulation and the structural defect drive the degenerative breakdown of the aortic media.
Progressive Aortic Dilation and Aneurysm
effector
The structurally weakened aortic wall cannot withstand pulsatile hemodynamic stress and progressively dilates, characteristically at the aortic root and ascending aorta, forming an aneurysm. The natural history of this dilation is progressive expansion, and aortic root aneurysms are the common problem across the syndromic aortopathies.
Downstream
-
Aortic Dissection and Rupture
Continued wall weakening and dilation culminate in dissection or rupture.
Aortic Dissection and Rupture
consequence
The conserved terminal consequence of the heritable aortopathies. The degenerated, dilated aortic wall is prone to dissection and rupture, the main life-threatening manifestation and leading cause of premature death. These complications give the aortopathies their clinical urgency and motivate surveillance and prophylactic repair across all conforming disorders.